Sarcoidosis associated with vemurafenib
- Funding sources: This work is supported in part by grants from Lyon 1 University (to L.T.), the Hospices Civils de Lyon (to L.T.) and the Ligue Contre le Cancer du Rhone (to L.T.).
- Conflicts of interest: none declared.
Correspondence: Stéphane Dalle.
No abstract is available for this article.